Premium Information is available for this item - Upgrade for $1 a day

2590-01-468-4316

Adapter

2590014684316 014684316 TXR78-AB00-1205A1 FV 2225676 ITEM 3 FV 2225676/3

2590-01-468-4316 ADAPTER 2590014684316 014684316

Managed by United States
NSN Created on 8 Oct 1999
Data Last Changed
January 2023
NATO Update Count
4
NATO Data Quality
2590-01-468-4316 ADAPTER 2590014684316 014684316 1/1
NSN 2590-01-468-4316 (Generic Image) 1/1

2590-01-468-4316 Stock and Availability Marketplace 2590-01-468-4316

Need Help?
Request a Quotation from participating marketplace vendors
eBay Updated Every Day
2590-01-468-4316 RQST NE eBay
eBay Updated Every Day
2590-01-468-4316 RQST eBay
Amazon Updated Every Day
2590-01-468-4316 RQST NE Amazon

2590-01-468-4316 Demil Restrictions 2590-01-468-4316

DEMIL: A | DEMILI: 1 | CRITICALITY: X | HMIC: N | PMIC: A | EDC: A | ADPEC: 0

2590-01-468-4316 is a Adapter that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item is not suspected to be hazardous. This item does not contain a precious metal.

2590-01-468-4316 End Users End Users 2590-01-468-4316

United Kingdom (ZK01)
Effective Date:
1 Oct 1999

2590-01-468-4316 Manufacturers Approved Sources 2590-01-468-4316

2590-01-468-4316 Technical Data Datasheet 2590-01-468-4316

Characteristic
Specifications
FIIG
A23900
End Item Identification [AGAV]
Challenger 2 Mbt

2590-01-468-4316 Related Items NATO Stock Numbers Related to 2590-01-468-4316

2590-01-468-4316 Freight Data Freight Information 2590-01-468-4316

2590-01-468-4316 has freight characteristics.. 2590-01-468-4316 has a variance between NMFC and UFC when transported by rail and the description should be consulted.